Founded in 1994, Polaris is leading biotech, which develops, produces, and formulates high value-added nutritional oils derived from microalgae. Thanks to its unique expertise in lipochemistry, the Group transforms crude oils into very high-quality concentrates through proprietary technological know-how and complex processes comprising refining, purification, deodorization, concentration, and stabilization.

As a true innovation platform, the Group relies on its patented QualitySilver® and GreenSilver® technologies, deployed in its industrial site in La Forêt-Fouesnant. Pioneer in microalgae-derived oils, Polaris has established itself as a unique partner to players in the nutraceutical, infant nutrition, and cosmetics industries.

Polaris microalgae solutions are adapted to the strictest requirements: 100% vegan, non-GMO, gluten-free, allergen-free and with strong organoleptic characteristics, offering a sustainable alternative to limited marine resources.

In June 2026, Motion Equity Partners invested in Polaris Group alongside its Management team and historical shareholders, with the ambition to double in size within five years by accelerating the Group’s international expansion, notably in the United States, further investing in innovation, and pursuing external growth opportunities.